Y08060

Y08060 is a selective BET inhibitor. Y08060 inhibits the viability of C4-2B and LNCaP cell lines with IC50 values of 3.23 and 4.41 μM. Y08060 can suppress colony formation as well as AR expression in prostate cancer cell line. Y08060 can be studied in prostate cancer research[1].

Product Specifications

CAS Number

[2222565-19-5]

UNSPSC

12352005

Target

Epigenetic Reader Domain

Related Pathways

Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

O=C1NC2=CC(OC)=C(NS(=O)(C3=CC(Br)=CC=C3OC)=O)C=C2OC1(C)C

Molecular Formula

C18H19BrN2O6S

Molecular Weight

471.32

References & Citations

[1]Xiang, Q., et al., (2018) . Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer. ACS medicinal chemistry letters, 9 (3), 262-267.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-32281JF646 0.1 mL

Rabbit Polyclonal Ran Antibody [Janelia Fluor 646]

Ask

View Details

RA27047-01 50 µL

MASP1 (light chain, Cleaved-Ile449) rabbit pAb

Ask

View Details

RA27047-02 100 µL

MASP1 (light chain, Cleaved-Ile449) rabbit pAb

Ask

View Details

MBS1212422-01 0.02 mg (E-Coli)

Recombinant Xenopus laevis Fibroblast growth factor 3 (fgf3)

Ask

View Details

MBS1212422-02 0.1 mg (E-Coli)

Recombinant Xenopus laevis Fibroblast growth factor 3 (fgf3)

Ask

View Details

MBS1212422-03 0.02 mg (Yeast)

Recombinant Xenopus laevis Fibroblast growth factor 3 (fgf3)

Ask

View Details